Lantheus Medical Imaging

Lantheus develops, manufactures and commercializes essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care. Its pioneering products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography, nuclear imaging and magnetic resonance imaging (MRI) technologies.
The Company's products are routinely used to diagnose coronary artery disease (CAD), congestive heart failure (CHF), stroke, peripheral vascular (PVD) and other diseases. In addition to Lantheus's diversified portfolio of commercialized imaging agents and products, it has a strong development pipeline of internally-discovered next generation, first-in-class imaging agents that use positron emission tomography (PET), MRI technologies focused on enhancing current imaging modalities and fulfilling unmet diagnostic medical imaging needs.

Company Growth (employees)
Type
Public
HQ
Billerica, US
Founded
1956
Size (employees)
465 (est)
Lantheus Medical Imaging was founded in 1956 and is headquartered in Billerica, US

Lantheus Medical Imaging Office Locations

Lantheus Medical Imaging has offices in Billerica, San Juan and Montréal
Billerica, US (HQ)
331 Treble Cove Rd
Montréal, CA
1111 Boulevard Dr.-Frederik-Philips, Suite 600
San Juan, PR
150 Calle Federico Acosta, Suite 1

Lantheus Medical Imaging Data and Metrics

Lantheus Medical Imaging Financial Metrics

Lantheus Medical Imaging's revenue was reported to be $81.4 m in Q1, 2017
USD

Revenue (Q1, 2017)

81.4 m

Gross profit (Q1, 2017)

39.8 m

Gross profit margin (Q1, 2017), %

49%

Net income (Q1, 2017)

4.1 m

EBIT (Q1, 2017)

11.9 m

Market capitalization (17-Aug-2017)

626.3 m

Cash (31-Mar-2017)

40.9 m
Lantheus Medical Imaging's current market capitalization is $626.3 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

283.7 m301.6 m293.5 m301.9 m

Revenue growth, %

6%(3%)3%

Cost of goods sold

206.3 m176.1 m157.9 m164.1 m

Gross profit

77.4 m125.5 m135.5 m137.8 m

Gross profit Margin, %

27%42%46%46%

Sales and marketing expense

34.7 m36.5 m

R&D expense

14.4 m12.2 m

General and administrative expense

43.9 m38.8 m

Operating expense total

96.4 m83.7 m93 m87.6 m

EBIT

(19 m)41.8 m42.5 m56.6 m

EBIT margin, %

(7%)14%14%19%

Interest expense

42.9 m42.3 m(38.7 m)(26.6 m)

Interest income

104 k27 k24 k

Pre tax profit

(60.7 m)26 k(11.8 m)28.3 m

Income tax expense

1 m1.2 m3 m1.5 m

Net Income

(61.7 m)(1.2 m)(14.7 m)26.8 m
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

73.3 m74.1 m76.5 m78 m73.1 m81.4 m

Cost of goods sold

40.6 m40.4 m42.8 m42.2 m39.4 m41.6 m

Gross profit

32.7 m33.7 m33.7 m35.8 m33.7 m39.8 m

Gross profit Margin, %

45%45%44%46%46%49%

Sales and marketing expense

9.2 m8.6 m9.3 m9.8 m8.7 m10.2 m

R&D expense

2.6 m2.5 m3 m2.6 m2.8 m5.4 m

General and administrative expense

15.4 m9.2 m9.5 m9.2 m10.1 m12.3 m

Operating expense total

27.3 m20.3 m21.9 m21.7 m21.6 m27.8 m

EBIT

5.4 m13.4 m17.7 m14.2 m12.6 m11.9 m

EBIT margin, %

7%18%23%18%17%15%

Interest expense

(13.9 m)(7.1 m)(7 m)(7 m)(6.8 m)(5.4 m)

Pre tax profit

(23.2 m)6.1 m10.7 m7.6 m4.2 m4.9 m

Income tax expense

1.2 m739 k390 k247 k20 k785 k

Net Income

(24.4 m)5.4 m10.3 m7.4 m4.2 m4.1 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

16.7 m17.8 m28.6 m51.2 m

Accounts Receivable

38.9 m41.5 m13.7 m36.8 m

Inventories

18.3 m15.6 m17.2 m17.6 m

Current Assets

77.3 m79.2 m90.1 m110.8 m

PP&E

97.7 m96 m86.5 m

Goodwill

15.7 m15.7 m15.7 m15.7 m

Total Assets

259.4 m247.5 m242.4 m255.9 m

Accounts Payable

18.1 m15.7 m18.9 m

Total Debt

11.7 m3.7 m

Current Liabilities

55.6 m48.5 m35.7 m43.8 m

Total Liabilities

362.4 m

Common Stock

303 k367 k

Additional Paid-in Capital

2.9 m3.9 m175.6 m226.5 m

Retained Earnings

(238.3 m)(239.5 m)(359.2 m)(332.4 m)

Total Equity

(185.3 m)(106.5 m)

Debt to Equity Ratio

-0.1 x0 x

Debt to Assets Ratio

0 x0 x

Financial Leverage

-1.3 x-2.4 x
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

22.2 m21.9 m38.9 m54.9 m53.2 m40.9 m

Accounts Receivable

39.9 m

Inventories

15.4 m16.6 m15.5 m14.4 m16.1 m19.8 m

Current Assets

79 m83.4 m100 m113 m110.5 m106.7 m

PP&E

92.9 m92.4 m85.3 m84.4 m

Goodwill

15.7 m15.7 m15.7 m15.7 m15.7 m15.7 m

Total Assets

233.6 m236.1 m249.3 m259.3 m255 m249.6 m

Accounts Payable

14.2 m10.7 m13 m12.8 m13.6 m17.6 m

Current Liabilities

37.5 m34.3 m31.5 m34.1 m39.1 m39.1 m

Common Stock

303 k303 k303 k303 k357 k371 k

Additional Paid-in Capital

174.6 m175.1 m176 m176.5 m216.8 m227.7 m

Retained Earnings

(368.5 m)(363.1 m)(348.8 m)(341.5 m)(337.3 m)(328.3 m)

Total Equity

(195.6 m)(190.1 m)(174.2 m)(166.4 m)(121.2 m)(101.2 m)

Financial Leverage

-1.2 x-1.2 x-1.4 x-1.6 x-2.1 x-2.5 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(61.7 m)(1.2 m)(14.7 m)26.8 m

Depreciation and Amortization

9.3 m9.9 m19.7 m18.3 m

Accounts Receivable

2.6 m(3.6 m)(1.1 m)

Inventories

1 m(882 k)(3.6 m)

Accounts Payable

(1.1 m)(4 m)5.7 m

Cash From Operating Activities

49.6 m

Capital Expenditures

(5 m)(8.1 m)(13.2 m)(7.4 m)

Cash From Investing Activities

3.3 m

Long-term Borrowings

(1.9 m)(78.7 m)

Cash From Financing Activities

(30.2 m)

Interest Paid

39.2 m39.2 m40.8 m24.4 m

Income Taxes Paid

187 k(112 k)

Free Cash Flow

42.2 m
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(24.4 m)5.4 m10.3 m7.4 m4.2 m4.1 m

Accounts Receivable

39.9 m

Inventories

15.4 m16.6 m15.5 m14.4 m16.1 m19.8 m

Accounts Payable

14.2 m10.7 m13 m12.8 m13.6 m17.6 m
USDY, 2017

Revenue/Employee

175 k

Financial Leverage

-2.5 x

Lantheus Medical Imaging Market Value History

Traffic Overview of Lantheus Medical Imaging

Lantheus Medical Imaging Company Life and Culture

You may also be interested in